Patents by Inventor Erik Mikal Kuester

Erik Mikal Kuester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphodiesterase 4 inhibitors
    Patent number: 7723348
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: May 25, 2010
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20090306156
    Abstract: Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I: wherein R1, R2, and R3 are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Application
    Filed: August 4, 2009
    Publication date: December 10, 2009
    Inventors: Allen HOPPER, Robert Francis Dunn, Erik Mikal Kuester, Richard Dennis Conticello, Ruiping Liu, Ashok Tehim
  • Phosphodiesterase 4 inhibitors
    Patent number: 7585882
    Abstract: Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I: wherein R1, R2, and R3 are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: September 8, 2009
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert Francis Dunn, Erik Mikal Kuester, Richard Dennis Conticello, Ruiping Liu, Ashok Tehim
  • Phosphodiesterase 4 inhibitors
    Patent number: 7432266
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: October 7, 2008
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20080207660
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Application
    Filed: April 24, 2008
    Publication date: August 28, 2008
    Inventors: Allen HOPPER, Robert F. Dunn, Erik Mikal Kuester, Richard D. Conticello